Bexero Sucks

Discussion in 'GlaxoSmithKline' started by anonymous, Feb 24, 2016 at 10:44 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    The better question is: "What is your market share?" if the answer is anything above zero, you should be embarrassed and ashamed. How do you with clear consience sell an inferior product that is intended to protect against such a devastating disease? With your child's life on the line, what protection would you prefer... 97% or 66%?? By the way, the California patient with 2 doses of BexZero onboard....If he had the opportunity to revisit the past....he would chose Trumenba vs. BexZero.

    2 doses of BexZero= O protection!! BexZero...can't make it for Europe....does not work in USA!!

    PS your bundle ponzi scheme would make Bernie Madoff proud!! gsk is the scum of this industry. go to hell you rat bastards
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest


    As I expected, crickets. F.U.
     
  5. anonymous

    anonymous Guest

    What don't you like about the bundle we are offering? My customers are loving it
     
  6. anonymous

    anonymous Guest

    Bexsero is running about 7% of the sales of Trumenba in the US.
     
  7. anonymous

    anonymous Guest

    Former NVS here. How is the turd (Bexsero) doing up in Canada? They had a good start from what I remember.
     
  8. anonymous

    anonymous Guest

    Wow, GSK should just be so thankful that Pfizer has finally brought to market a mening b vaccine to save the US.

    This is all such a load. Would the pathetic, data distorting Pfizer reps just go back to their own board and cry about the $400 million they just had to pay to Allergan for blowing up their merger deal.

    You can make up all this bs with customers to take their eye of the fact you are 3 doses and we are 2 and they will never finish your series. Which is why you keep telling customers "but we have submitted our 2 dose data to the fda for approval". Well, if it was so compelling to begin with, you'd already be approved for it. Sorry you lose. The HPV completion rate is the best example of 3 doses don't work. Don't try to tie yours to Merck's because then customers just end up with 2 incomplete series rather than one.

    But keep telling your lies. It really makes this fun.
     
  9. anonymous

    anonymous Guest

    Pfizer (noun of Germanic origin): definition - 1) US Pharmaceutical Company that only adds new therapies by hostile acquisitions due to poorly performing R&D and Sales teams; 2) An anal seeking small mammal that seeks nourishment from the ingestion of feces of other animals.
     
  10. anonymous

    anonymous Guest


    does GSK even have R&D anymore? And BTW, what role does a sales team have in adding new therapies??
     
  11. anonymous

    anonymous Guest

    Hey kid, go study your products if you are bored. Work hard and follow orders....that's all you need to do, and all you need to worry about. Let the big boys worry about the big things.
     
  12. anonymous

    anonymous Guest

    Trumenba is now 2 doses if the doc wants to. Some will stay at 3
     
  13. anonymous

    anonymous Guest

    Wow 0 and 6 months. Good luck with that.
     
  14. anonymous

    anonymous Guest

    Unlike Bexzero, Trumenba works.
     
  15. anonymous

    anonymous Guest

    LOL. You guys are a joke. Go back to selling Prevnar. Oh yeah, you don't have to.
     
  16. anonymous

    anonymous Guest

    gsk, you guys are a joke....go back to selling whatever else is in your bag. Oh yeah, you don't.
    F.U.
     
  17. anonymous

    anonymous Guest

    Nice come back Fez. Let's just let the numbers speak for themselves and pick this debate up in a few months.